Recall: Spacelabs Healthcare pulls anesthesia workstations over excess CO2 risk

March 27, 2013 by Arezu Sarvestani

The FDA puts its highest-risk label on Spacelabs Healthcare's anesthesia workstation recall over concerns that a defect resulting in excess carbon dioxide concentration in inhaled gas may lead to patient harm or even death.

Spacelabs Medical logo

Washington-based Spacelabs Healthcare recalled a slate of its Spacelabs BleaseSirius and BleaseFocus anesthesia workstations as well as certain absorbers contained in service kits over concerns that they may contain a defect which could result in excess carbon dioxide in the gas delivered to a patient.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.